Stockscreener 앱 받기
76.30
0.74%
0.56
시간 외 거래:
76.30
전일 마감가:
$75.74
열려 있는:
$76.97
하루 거래량:
1.35M
Relative Volume:
0.99
시가총액:
$8.69B
수익:
$13.18B
순이익/손실:
$419.00M
주가수익비율:
23.33
EPS:
3.2704
순현금흐름:
$521.00M
1주 성능:
-0.03%
1개월 성능:
+5.94%
6개월 성능:
+4.33%
1년 성능:
+8.40%
1일 변동 폭
$76.20
$77.53
1주일 범위
$75.44
$78.04
52주 변동 폭
$61.95
$89.29
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.30 | 8.63B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
756.95 | 88.89B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
270.32 | 51.29B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
201.74 | 45.87B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.46 | 1.24B | 14.85M | -136.07M | 7.25M | -0.4726 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-16 | 개시 | BTIG Research | Neutral |
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report? - Yahoo Finance
Henry Schein sees steady dental demand, $125M profit lift by 2026 - MSN
Henry Schein (HSIC) Q1 2026 Earnings Transcript - AOL.com
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring A 13.89% Potential Upside - DirectorsTalk Interviews
How Henry Schein’s New Chairman and Governance Shift At Henry Schein (HSIC) Has Changed Its Investment Story - simplywall.st
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein Assures 2026 Financial Goals Amid Steady Dental Demand - HarianBasis.co
Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026 - Barchart.com
Here's why Henry Schein (HSIC) is a strong momentum stock - MSN
Henry Schein (NASDAQ: HSIC) SVP files Form 3 on share and option holdings - Stock Titan
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock - Yahoo Finance
Is This the Right Time to Keep HSIC Stock in Your Portfolio? - TradingView
Dental giant Henry Schein announces new independent chairman of the board - Dental Tribune US
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein (HSIC) ex-director corrects date on 50-share stock gift - Stock Titan
Henry Schein stock (US42548G1040): Dental and medical distributor navigates shifting US healthcare d - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside - DirectorsTalk Interviews
Henry Schein highlights dental momentum, $125M savings goal despite medical softness - MSN
Henry Schein Names New Independent Chairman Amid Governance Shift - The Globe and Mail
Henry Schein appoints William Daniel as independent chairman - Investing.com UK
Henry Schein (HSIC) director reports bona fide 50-share stock gift - Stock Titan
Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board, Succeeding Stan Bergman After 44 Years - Minichart
Henry Schein appoints William Daniel as independent chairman By Investing.com - Investing.com South Africa
Henry Schein, Inc. (HSIC) Announces Key Decisions from 2026 Annu - GuruFocus
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein Names William K. Daniel as Independent Chairman - Moomoo
Henry Schein Names New Board Chairman - Dentistry Today
Henry Schein announces the election of William K. "Dan" Daniel as independent chairman of the board - marketscreener.com
Dan Daniel becomes Henry Schein (HSIC) independent chair as Bergman retires - Stock Titan
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board - Business Wire
Henry Schein Governance Push Meets Discounted Valuation And Mixed Share Performance - Sahm
Henry Schein (HSIC) director Stanley Bergman gifts 1,040 shares - Stock Titan
Henry Schein stock (US42548G1040): Q1 2026 results and outlook update put margins in the spotlight - AD HOC NEWS
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance - Yahoo Finance
Henry Schein Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Henry Schein stock (US42548G1040): Q1 results and outlook update draw investor focus - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution - DirectorsTalk Interviews
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness - MarketBeat
A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance - Sahm
Why Henry Schein (HSIC) is a top value stock for the long term - MSN
Citigroup initiates coverage of Henry Schein (HSIC) with buy recommendation - MSN
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail
LONE PEAK VALUE FUND's Henry Schein Inc(HSIC) Holding History - GuruFocus
An Insider Of Henry Schein Picks Up 100% More Stock - simplywall.st
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - Yahoo Finance
Henry Schein Inc (HSIC) Stock Up 4.5% and Still Undervalued -- G - GuruFocus
Henry Schein One Releases 2026 Catalyst Index - Dentistry Today
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth - 01net
Henry Schein Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Henry Schein (HSIC) director boosts stake with 10,000-share open-market buy via trust - Stock Titan
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
10.27%
자본화:
|
볼륨(24시간):